| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.906 | 10.815 | 1.591 | 0 | 1.465 | 0 | 0 | 27.208 | 71.448 | 127.419 |
| Total Income - EUR | 2.906 | 10.815 | 1.591 | 0 | 1.465 | 0 | 0 | 27.209 | 71.449 | 127.422 |
| Total Expenses - EUR | 8.726 | 9.622 | 2.789 | 5.294 | 5.076 | 1.775 | 3.033 | 56.619 | 80.790 | 119.893 |
| Gross Profit/Loss - EUR | -5.820 | 1.194 | -1.197 | -5.294 | -3.612 | -1.775 | -3.033 | -29.410 | -9.341 | 7.530 |
| Net Profit/Loss - EUR | -5.907 | 869 | -5.738 | -5.294 | -3.656 | -1.775 | -3.033 | -29.683 | -10.055 | 3.815 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 2 | 3 | 4 |
Check the financial reports for the company - Bioplasm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.892 | 1.626 | 1.561 | 1.532 | 1.503 | 1.474 | 1.825 | 8.867 | 5.648 | 65.701 |
| Current Assets | 1.261 | 1.192 | 162 | 1.993 | 2.257 | 1.796 | 2.206 | 44.882 | 73.686 | 37.315 |
| Inventories | 1.108 | 1.096 | 0 | 1.942 | 1.905 | 1.660 | 1.811 | 8.055 | 10.233 | 11.092 |
| Receivables | 13 | 13 | 0 | 0 | 0 | 0 | 37 | 36.809 | 57.855 | 18.617 |
| Cash | 140 | 82 | 162 | 50 | 352 | 136 | 358 | 18 | 5.597 | 7.607 |
| Shareholders Funds | -93.805 | -91.980 | -96.162 | -99.691 | -101.417 | -101.269 | -102.071 | -132.071 | -141.726 | -137.119 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 96.959 | 94.797 | 97.885 | 103.217 | 105.176 | 104.539 | 106.102 | 186.061 | 221.139 | 240.241 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Bioplasm S.r.l.